Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02508467
Title A Phase 1 Study of BLU-554 in Patients With Hepatocellular Carcinoma and Cholangiocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Blueprint Medicines Corporation
Indications

hepatocellular carcinoma

cholangiocarcinoma

Therapies

Fisogatinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.